Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Return on Capital Employed (2016 - 2026)

Iradimed has reported Return on Capital Employed over the past 13 years, most recently at 7.8% for Q1 2026.

  • Quarterly Return on Capital Employed fell 1693.0% to 7.8% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 7.8% through Mar 2026, down 1693.0% year-over-year, with the annual reading at 6.38% for FY2025, 1895.0% down from the prior year.
  • Return on Capital Employed was 7.8% for Q1 2026 at Iradimed, up from 5.86% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 27.28% in Q4 2023 and troughed at 5.86% in Q4 2025.
  • The 5-year median for Return on Capital Employed is 24.74% (2025), against an average of 21.56%.
  • Year-over-year, Return on Capital Employed skyrocketed 1515bps in 2022 and then plummeted -1916bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 21.13% in 2022, then increased by 29bps to 27.28% in 2023, then fell by -8bps to 25.02% in 2024, then crashed by -77bps to 5.86% in 2025, then soared by 33bps to 7.8% in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Return on Capital Employed are 7.8% (Q1 2026), 5.86% (Q4 2025), and 25.42% (Q3 2025).